معرفی
Dr. Stephanie Wemm is an Associate Research Scientist in the Department of Psychiatry at Yale School of Medicine, affiliated with the Yale Stress Center and other research groups. She holds a PhD in Clinical Psychology from the University at Albany, SUNY, and completed a predoctoral internship at Brown University’s Warren Alpert Medical School. Her research focuses on the interplay between stress and substance/behavioral addictions, employing both laboratory and real-world methodologies. Key collaborations include work with Dr. Rajita Sinha and colleagues on studies involving guanfacine’s effects on addiction recovery, stress biomarkers in polysubstance use disorders, and neurosteroid interventions for alcohol use disorder. Dr. Wemm has contributed to over 30 peer-reviewed publications and is involved in clinical trials investigating stress-related mechanisms in cannabis use and polysubstance misuse. She is also a principal investigator for studies leveraging digital technologies to track real-world stress and recovery patterns in addiction.
Education:
- PhD in Clinical Psychology, University at Albany, SUNY (2017)
- MA in Psychology, University at Albany, SUNY (2014)
- MA in Clinical Psychology, Marshall University (2010)
- BA in Psychology, Marshall University (2006)
Research Interests: Stress physiology, substance use disorders, neurosteroids, clinical trials in addiction recovery, real-world monitoring of craving and relapse, and the role of stress in polysubstance misuse. Her work integrates behavioral, neurobiological, and pharmacological approaches to understand addiction mechanisms and develop targeted interventions.
Publications Overview: Recent work emphasizes pharmacological treatments for polysubstance use disorder (e.g., guanfacine), real-world stress reactivity in cannabis use, and the role of pregnenolone in alcohol craving. Her studies highlight translational research bridging lab findings to clinical practice, with a focus on improving treatment outcomes for women and underserved populations.
Grants & Collaborations: Active collaborations with the Yale Stress Center and Yale Center for the Science of Cannabis and Cannabinoids. Principal investigator on studies funded by NIH/NIDA and other agencies, focusing on stress biomarkers and digital health interventions in addiction recovery.
Labs/Teams: Core member of the Yale Stress Center, where she leads projects on neurosteroid interventions and real-world stress monitoring in addiction research.